NASDAQ:PYXS | Free Cash Flow | Pyxis Oncology, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$26M
2025-12-31-$10.43M$0.00-$10.43M
2025-03-31-$22.54M
2024-12-31-$19.29M$0.00-$19.29M
2024-03-31-$20.71M$237,000.00-$20.95M
2023-12-31-$15.25M$0.00-$15.25M
2023-03-31-$26.84M$4.41M-$31.25M
2022-12-31-$17.39M$1.86M-$19.25M
2022-03-31-$27.68M$146,000.00-$27.83M
2021-12-31-$12.17M$0.00-$12.17M
2021-03-31-$18.73M$169,000.00-$18.9M
2020-12-31-$3.17M$0.00-$3.17M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$63.5M$9,000.00-$63.51M
2024-12-31-$57.67M$237,000.00-$57.91M
2023-12-31-$70.71M$6.73M-$77.44M
2022-12-31-$89.34M$6.4M-$95.73M
2021-12-31-$35.33M$540,000.00-$35.87M
2020-12-31-$10.08M$1.48M-$11.57M